Sometimes the market's message is brutally simple: dilution hurts. That's exactly what happened to Intelligent Bio Solutions Inc. (INBS) on Friday, as shares cratered following the company's announcement that it plans to raise $10 million through a private placement. When you're adding new shares to the mix, existing shareholders get a smaller piece of the pie, and the market wasted no time pricing that in.

Intelligent Bio Solutions shares fell 19.7% to $7.65 during Friday's session, a textbook example of how capital raises can spook investors even when the company presumably needs the money for growth. It's not personal, it's just math.

But Friday's trading action extended far beyond one biotech company's financing woes. The session delivered a wild mix of dramatic gains and painful losses across multiple sectors, with some stocks more than doubling while others got cut in half. Here's the full rundown of what moved.

The Winning Side

If you're looking for Friday's hero, Lavoro Limited (LVRO) takes the crown with an absolutely massive 181% surge to $1.29. That's the kind of move that makes you either very happy or very sad depending on which side of the trade you were on.

Ironwood Pharmaceuticals, Inc. (IRWD) had a pretty spectacular day itself, climbing 57.7% to $5.32 after laying out its 2026 roadmap. The company's guidance paints an optimistic picture: Linzess US net sales are expected to hit between $1.125 billion and $1.175 billion, with total revenue projected at $450 million to $475 million. Perhaps most importantly for investors, Ironwood expects adjusted EBITDA to exceed $300 million in 2026. Those are the kinds of numbers that get people excited.

Brand Engagement Network, Inc. (BNAI) jumped 56% to $3.63 following news that it secured a Vendor Services Project Agreement with a global advertising and communications agency. The market clearly liked the partnership potential.

Over at ChowChow Cloud International Holdings Limited (CHOW), shares rose 39.7% to $0.85 after the company reported year-over-year increases in both H1 2025 revenue and net income. When the top and bottom lines are both moving in the right direction, investors tend to notice.

Aimei Health Technology Co., Ltd (AFJK) gained 34.2% to $85.90, though the company didn't disclose specific catalysts for the move.

Sidus Space, Inc. (SIDU) continued its remarkable run, gaining 29% to $4.03. This extends what the company describes as a "volatile but powerful rally" that has seen the stock surge approximately 470% over the past month. That's either momentum trading at its finest or something fundamental changing in the business, depending on who you ask.

SMX (Security Matters) Public Limited Company (SMX) gained 27.8% to $20.90, while WORK Medical Technology Group LTD (WOK) rose 24.4% to $2.71.

SELLAS Life Sciences Group, Inc. (SLS) climbed another 22.2% to $4.61, building on Wednesday's 14% gain. Biotech momentum can be persistent when it gets going.

Sable Offshore Corp. (SOC) gained 20.2% to $10.94, getting a boost from Benchmark analyst Subash Chandra who reiterated a Buy rating and maintained a $20 price target. That represents roughly 80% upside from current levels if the analyst's thesis plays out.

T1 Energy Inc. (TE) rose 17.7% to $7.86, while SkyWater Technology, Inc. (SKYT) climbed 16.1% to $21.09.

The tech sector had its own winners. Baidu, Inc. (BIDU) rose 12.1% to $146.57 after announcing plans to spin off and list its non-wholly owned AI unit Kunlunxin on the Hong Kong exchange. Investors love a good spinoff story, especially when artificial intelligence is involved.

Denison Mines Corp. (DNN) gained 10.3% to $2.94 as the uranium miner announced it's ready to commence construction of its flagship Phoenix ISR project and issued a capital cost update. With nuclear energy back in the spotlight, uranium plays are getting renewed attention.

Among the mega-cap names, Sandisk Corporation (SNDK) rose 10.1% to $261.28, Corcept Therapeutics Incorporated (CORT) climbed 9.2% to $37.98, and Astera Labs, Inc. (ALAB) gained 9.1% to $181.53.

The semiconductor sector showed strength across the board. ASML Holding N.V. (ASML) rose 8.7% to $1,163.31, while Intel Corporation (INTC) gained 7.1% to $39.51.

Vertiv Holdings Co (VRT) rose 7.4% to $174.08 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $181 to $200. Analyst upgrades with meaningful price target increases tend to move stocks, and this was no exception.

The Losing Side

If Lavoro Limited had Friday's best performance, Outlook Therapeutics, Inc. (OTLK) definitely had the worst. Shares plunged 58% to $0.66 after the FDA issued a complete response letter to the company's ONS-5010/LYTENAVA biologics license application resubmission. Translation: the FDA cannot approve the application in its present form for the treatment of wet age-related macular degeneration. That's about as bad as regulatory news gets in biotech, and the market reacted accordingly.

ESH Acquisition Corp. (ESHA) fell 23.5% to $14.68, while Semilux International Ltd. (SELX) dipped 22.2% to $0.63.

Oriental Rise Holdings Limited (ORIS) dropped 20% to $1.19, matching the percentage decline we saw in Intelligent Bio Solutions, though for potentially different reasons.

LZ Technology Holdings Limited (LZMH) dipped 18% to $1.37, while X3 Holdings Co., Ltd. (XTKG) also fell 18% to $0.30.

Nuvve Holding Corp. (NVVE) declined 15.3% to $2.15 even after announcing the closing of a private placement of Series A preferred stock and warrants. Like Intelligent Bio, it seems the market wasn't thrilled about the dilution implications.

UTime Limited (WTO) dipped 14.7% to $0.87, while Starfighters Space, Inc. (FJET) fell 12% to $10.26.

Jyong Biotech Ltd. (MENS) declined 9.6% to $3.57, and Liquidia Corporation (LQDA) fell 9.2% to $31.31.

Healthcare Services Group, Inc. (HCSG) dropped 7.7% to $17.64, while Jade Biosciences, Inc. (JBIO) fell 7.3% to $14.30.

Finally, Innovative Aerosystems, Inc. (ISSC) declined 6.6% to $17.68, rounding out Friday's notable decliners.

The breadth of movement across so many names and sectors shows just how active Friday's mid-day session was. From triple-digit percentage gains to devastating regulatory rejections, the market served up a little bit of everything. For investors in any of these names, it was definitely not a boring day.